Gross Margin
15.07%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.18%.Updated Sep 21, 2026Profit Margin
-2.75%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Margin
3.11%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Assets (TTM)
-0.25%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Equity (TTM)
-2.08%vs Specialty Chemicals peers Updated Sep 21, 2026Revenue (TTM)
1.37BCNY203.85M · vs all stocks (USD) Updated Sep 21, 2026Revenue per Share (TTM)
2.90CNYUpdated Sep 21, 2026Quarterly Revenue Growth
36.20%vs Specialty Chemicals peers Updated Sep 21, 2026Gross Profit (TTM)
139.01MCNY20.74M · vs all stocks (USD) Updated Sep 21, 2026EBITDA (TTM)
152.97MCNY22.83M · vs all stocks (USD) Updated Sep 21, 2026Net Income (TTM)
-37.59MCNY-5.61M · vs all stocks (USD) Updated Sep 21, 2026Quarterly Earnings Growth (YoY)
191.00%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Cash Flow (TTM)
86.25MCNY12.87M · vs all stocks (USD) Updated Sep 21, 2026Levered Free Cash Flow (TTM)
-162.02MCNY-24.18M · vs all stocks (USD) Updated Sep 21, 20265-Year Average Dividend Yield
0.27%Updated Sep 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 21, 2026Revenue
1.18BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.04BCNYFY2025 · Dec 31, 2025Gross Profit
140.12MCNYFY2025 · Dec 31, 2025Operating Income
1.77MCNY264.40K · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-26.03MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.15MCNYFY2025 · Dec 31, 2025Net Income
-35.18MCNYFY2025 · Dec 31, 2025EBIT
-6.85MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
152.97MCNYFY2025 · Dec 31, 2025Research & Development
49.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
27.36MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.33MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
19.18MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0750CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0750CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
469.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
469.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-35.18MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-184.05MCNYFY2025 · Dec 31, 2025Free Cash Flow
-343.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
96.29MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-35.18MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.99MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-44.67MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-123.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-159.83MCNYFY2025 · Dec 31, 2025Purchase of Investments
-273.00MCNYFY2025 · Dec 31, 2025Sale of Investments
297.42MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-135.41MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
191.09MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-206.81MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-12.70MCNYFY2025 · Dec 31, 2025Other Financing Charges
69.70MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
41.28MCNYFY2025 · Dec 31, 2025